Simulations Plus, Inc. hosted the workshop titled Biopharma AI Operating Platform and in silico Early-Stage ADME/PK/PD Modeling for Beginners: Introduction to Real-World Application Cases at the Korea Chapter of the Pharmaceutical & BioScience Society International (Korea-PBSS)
Public source
Publisher name
Public post
Thank you to everyone who participated in the recent workshop, “Biopharma AI Operating Platform and in silico Early-Stage ADME/PK/PD Modeling for Beginners: Introduction…
Company
Simulations Plus, Inc.
Where are you in the drug development process? Save resources & get to market faster with our solutions!
- Industry
- Software Development
- Location
- Durham, US
- Company size
- 201–500 employees
About Simulations Plus, Inc.
Simulations Plus is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. We offer solutions that bridge artificial intelligence (AI) and machine learning (ML), physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, chemical, and consumer goods companies, and regulatory agencies worldwide. For more information visit us at www.simulations-plus.com
See moreLatest activity
Latest activity from Simulations Plus, Inc.
8 signals
Presence & Recognition
Simulations Plus, Inc. experts Lynzie Worth and Jenna Rouse will be at DPHARM 2026
Research & Knowledge
Simulations Plus, Inc. published a blog post by Dr. Jeremy Jones discussing where mechanistic modeling and AI are intersecting in the discovery space.
Presence & Recognition
Simulations Plus, Inc. hosted Jeremy Jones hosting the ADMETPredictor v14 webinar on September 16 at 11 AM EDT.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
Chemical Computing Group
Chemical Computing Group participated in the EFMC-ISMC 2026 workshop on practical structure-based drug design workflows for medicinal chemistry, focusing on drug discovery projects.
Presence & Recognition
OpenADMET
OpenADMET hosted a final webinar in the PXR challenge seminar series featuring the winners of the activity track.
Presence & Recognition
Admescope
Admescope is participating in the PBSS Workshop on September 9, 2026, in Cambridge, MA, titled IND Filing and Nonclinical Considerations for Emerging Modalities: Protein Degraders, Oral Peptides, and Oligonucleotide.
Presence & Recognition
Lhasa Limited
Lhasa Limited is hosting an upcoming symposium bringing together experts and peers to share ideas on pharmaceutical safety and risk assessment.
Presence & Recognition
ESQlabs